Black Diamond Therapeutics Inc. Watch

from 10-Q 19 pages Employment Agreement

from 10-Q 7 pages October 4, 2024 Fang Z. Ni, PHARM.D. Re: Notice of Termination and Separation Agreement Dear Fang

from 10-K 2 pages Black Diamond Therapeutics, Inc. Fifth Amended and Restated Non-Employee Director Compensation Policy

from 10-K 12 pages Employment Agreement

from 10-K 15 pages Black Diamond Therapeutics, Inc. 2020 Employee Stock Purchase Plan

from 8-K 22 pages Employment Agreement

from 8-K 7 pages September 17, 2023 David M. Epstein, Phd Re: Notice of Termination and Separation Agreement · the Company Will, if It Has Not Already Done So, Pay You Any Accured Obligations, as That Term Is Defined in the Employment Agreement; · the Company Will Provide You With the Right to Continue Group Health Plan Coverage After the Termination of Your Employment Under the Law Known as “Cobra,” Which Will Be Described in a Separate Written Notice; · Your Eligibility to Participate in Any Other Employee Benefit Plans and Programs of the Company Will Cease on or After the Separation Date in Accordance With the Applicable Benefit Plan or Program Terms and Practices; · the Equity Awards Held by You Shall Be Governed by the Terms and Conditions of the Company’s Applicable Equity Incentive Plan(s) and the Applicable Award Agreement(s) Governing the Terms of Such Equity Awards (Collectively, the “Equity Documents”); And

from 10-K 2 pages Black Diamond Therapeutics, Inc. Fourth Amended and Restated Non-Employee Director Compensation Policy

from 10-K 17 pages Employment Agreement

from 10-K 13 pages Employment Agreement

from 10-Q 12 pages Employment Agreement

from 10-Q 2 pages Black Diamond Therapeutics, Inc. Third Amended and Restated Non-Employee Director Compensation Policy

from 10-Q 16 pages Employment Agreement

from 10-K 16 pages Employment Agreement

from 10-Q 42 pages Lease Rreef America REIT II Corp. Ppp, Landlord, and Black Diamond Therapeutics, Inc., Tenant Riverfront Office Park Cambridge, Massachusetts

from 10-K 6 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) Would Likely Cause Competitive Harm to the Company if Disclosed. Amendment No. 3 to Services Agreement

from S-1/A 14 pages Black Diamond Therapeutics, Inc. 2020 Employee Stock Purchase Plan

from S-1/A 72 pages Black Diamond Therapeutics, Inc. 2020 Stock Option and Incentive Plan

from S-1 17 pages Services Agreement

from S-1 74 pages 139 Main Street Cambridge, Massachusetts Lease Summary Sheet